Johnson & Johnson (JNJ)
283.52
+3.11
(+1.11%)
USD |
NYSE |
Nov 12, 16:00
284.44
+0.92
(+0.32%)
Pre-Market: 04:46
Johnson & Johnson Price to Book Value : 8.371 for Nov. 12, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 12, 2026 | 8.371 |
| November 11, 2026 | 8.279 |
| November 10, 2026 | 8.290 |
| November 09, 2026 | 8.329 |
| November 06, 2026 | 8.155 |
| November 05, 2026 | 8.040 |
| November 04, 2026 | 8.158 |
| November 03, 2026 | 7.859 |
| November 02, 2026 | 7.988 |
| October 30, 2026 | 8.066 |
| October 29, 2026 | 8.125 |
| October 28, 2026 | 8.002 |
| October 27, 2026 | 7.934 |
| October 26, 2026 | 7.862 |
| October 23, 2026 | 7.789 |
| October 22, 2026 | 7.901 |
| October 21, 2026 | 7.611 |
| October 20, 2026 | 7.658 |
| October 19, 2026 | 7.493 |
| October 16, 2026 | 7.545 |
| October 15, 2026 | 7.478 |
| October 14, 2026 | 7.497 |
| October 13, 2026 | 7.340 |
| October 12, 2026 | 7.786 |
| October 09, 2026 | 7.719 |
| Date | Value |
|---|---|
| October 08, 2026 | 7.572 |
| October 07, 2026 | 7.631 |
| October 06, 2026 | 7.522 |
| October 05, 2026 | 7.468 |
| October 02, 2026 | 7.559 |
| October 01, 2026 | 7.637 |
| September 30, 2026 | 7.816 |
| September 29, 2026 | 7.583 |
| September 28, 2026 | 7.708 |
| September 25, 2026 | 7.687 |
| September 24, 2026 | 7.672 |
| September 23, 2026 | 7.629 |
| September 22, 2026 | 7.629 |
| September 21, 2026 | 7.637 |
| September 18, 2026 | 7.652 |
| September 17, 2026 | 7.658 |
| September 16, 2026 | 7.575 |
| September 15, 2026 | 7.573 |
| September 14, 2026 | 7.548 |
| September 11, 2026 | 7.527 |
| September 10, 2026 | 7.549 |
| September 09, 2026 | 7.570 |
| September 08, 2026 | 7.627 |
| September 04, 2026 | 7.800 |
| September 03, 2026 | 7.891 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Eli Lilly & Co. | 33.36 |
| Merck & Co., Inc. | 8.075 |
| Pfizer Inc. | 1.846 |
| Bristol Myers Squibb Co. | 5.443 |
| Abbott Laboratories | 3.640 |
Price to Book Value Related Metrics
| PE Ratio | 43.01 |
| PS Ratio | 6.973 |
| Price to Free Cash Flow | 34.67 |
| Price | 283.52 |
| Earnings Yield | 2.33% |
| Market Cap | 682.47B |
| Operating PE Ratio | 26.98 |
| Normalized PE Ratio | 30.57 |